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ABSTRACT 
 
Background/Aims: In cerebral arteries, NO release plays a key role in suppressing vasomotion. Our 
aim was to establish the pathways affected by NO in rat middle cerebral arteries. Methods: In isolated 
segments of artery, isometric tension and simultaneous measurements of either smooth muscle 
membrane potential or [Ca2+]SMC changes were recorded. Results: In the absence of L-NAME, 
asynchronous propagating Ca2+ waves were recorded that were sensitive to block with ryanodine, but 
not nifedipine. L-NAME stimulated pronounced vasomotion and synchronous Ca2+ oscillations with 
close temporal coupling between membrane potential, tone and [Ca2+]SMC. If nifedipine was applied 
together with L-NAME, [Ca2+]SMC decreased and synchronous Ca2+ oscillations were lost, but 
asynchronous propagating Ca2+ waves persisted. Vasomotion was similarly evoked by either IbTx, or 
by ryanodine, and to a lesser extent by ODQ. Exogenous application of NONOate stimulated 
endothelium-independent hyperpolarization and relaxation of either L-NAME-induced or spontaneous 
arterial tone. NO-evoked hyperpolarization involved activation of BKCa-channels via RYRs, with little 
involvement of sGC. Further, in whole cell mode, NO inhibited current through L-type VGCC (ICaL), 
which was independent of both voltage and sGC. Conclusion: NO exerts sGC-independent actions at 
RYRs and at VGCC, both of which normally suppress cerebral artery myogenic tone. 
Keywords: nitric oxide, membrane potential, calcium signaling, vascular smooth muscle, cerebral 
arteries, vasomotion 
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INTRODUCTION 
 
Cerebral arteries typically display spontaneous, submaximal constriction that is dependent on the level 
of intraluminal pressure or isometric stretch, termed myogenic tone. This myogenic tone is an essential 
mechanism in the local control of blood flow and tissue perfusion in the cerebral vasculature both in 
vivo and in vitro, and in many other vascular beds [1,2]. The development of myogenic tone is 
generally characterised by vascular smooth muscle cell depolarization, leading to an increase in the 
intracellular [Ca2+] ([Ca2+]SMC) and associated constriction of the artery [1,3]. Myogenic responses, by 
definition, can occur without a functional endothelial cell layer; however, the endothelium can 
considerably modulate the degree of myogenic tone by releasing a number of factors including nitric 
oxide (NO), prostacyclin and endothelium-derived hyperpolarizing factor. 
 
In addition to suppressing myogenic tone, endothelium-derived factors also modulate the vasomotion 
that often occurs in tandem with the development of myogenic constriction. Vasomotion describes 
rhythmic oscillations in tension or diameter that are normally synchronous with oscillations in Ca2+ and 
membrane potential (Em). In the brain, oscillations in middle cerebral artery blood flow velocity (as a 
result of vasomotion) have been observed in many species, including humans [4] and rats [5]. The role 
of the endothelium in the control of vasomotion is unclear; in some vascular beds the NO/cGMP 
pathway has been shown to augment vasomotion [6]. However in other beds, including the cerebral 
vasculature [5,7], NO/cGMP attenuates this response as NOS inhibitors stimulate vasomotion. This 
vasomotion manifests as a reduction in capillary blood flow, which tends to oscillate in synchrony 
within the bed [8]. Therefore any disruption of the ability to synthesize NO can potentially lead to 
vasomotion and/or spasm, as observed under pathophysiological conditions such as subarachnoid 
haemorrhage [9,10]. 
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In arteries isolated from both coronary [11,12] and cerebral [13-20] beds, a continual, basal release of 
NO suppresses myogenic tone, with inhibition of NO synthase (NOS) leading to depolarization and 
constriction in the absence of vasoconstrictor agents. NO can either stimulate hyperpolarization and 
closure of voltage-gated Ca2+ channels (VGCC), or directly close VGCC, both of which suppress 
myogenic tone. In terms of hyperpolarization, NO can activate smooth muscle cell BKCa-channels 
either directly [21-23] or via PKG-dependent mechanisms [24,25]. NO can also stimulate ryanodine-
sensitive calcium stores (by opening the ryanodine receptor, RYR) in the sarcoplasmic reticulum, 
evoking discrete calcium events termed ‘sparks’ that activate adjacent clusters of BKCa-channels. This 
mechanism has been suggested to underpin NO-dependent relaxation in the rat posterior cerebral artery 
[26] where the presence of NO is reported to be a prerequisite to activate the RYRs. Stimulation of 
RYRs by NO could be either direct or indirect, e.g. nitrosylation of thiol groups [27], or via cGMP 
mediated phosphorylation of the channel and the sarcoplasmic  reticulum calcium ATPase [28], 
respectively. In addition, NO can close VGCC in a membrane potential-independent manner, which 
can occur either via sGC/PKG [29-31], and/or by nitrosylation [32-34]. 
 
Therefore we investigated further the mechanisms underlying the modulation of myogenic tone and the 
development of vasomotion associated with the basal release of NO in the rat (middle) cerebral arteries. 
Although our data support the suggestion that NO does stimulate RYR channels to release calcium that 
drives BKCa-channel mediated hyperpolarization, they also suggest two further important aspects of 
NO activity. First, that inhibition of NO synthase masks (rather than inhibits) spontaneous oscillations 
in smooth muscle cell calcium due to activation of VGCCs and the appearance of vasomotion, which is 
consistent with activation of RYRs via NO-independent pathways. Second, a direct inhibitory action of 
NO on VGCCs can suppress cerebral artery myogenic tone. 
 5 
 
MATERIALS AND METHODS 
 
Male Wistar rats (200-300 g) were euthanized using procedures defined by the Animals (Scientific 
Procedures) Act 1986, UK (Schedule 1 procedure) and the brain was rapidly removed and stored 
immediately in ice-cold physiological salt solution for a maximum of 30 min.  
 
Simultaneous measurement of tension and membrane potential 
 
A 2 mm segment of the middle cerebral artery (internal diameter of ~175 µm) was mounted in a 
Mulvany-Halpern myograph (model 410A, Danish Myotechnology) in Krebs solution containing 
(mM): NaCl, 118.0; NaCO3, 25; KCl, 3.6; MgSO4⋅7H2O, 1.2; KH2PO4, 1.2; glucose, 11.0; CaCl2, 2.5; 
and gassed with 95 % O2 and 5 % CO2 at 37 ºC. The vessels were allowed to equilibrate for 20 min and 
were then tensioned to 1-1.5 mN (approximates wall tension at 60 mmHg). Vessel viability was 
assessed by the addition of exogenous K+ (15-55 mM), only vessels developing tension ≥3 mN were 
used. Endothelial cell viability was assessed by the ability of SLIGRL (20 µM; a protease-activated 
receptor 2 ligand) to relax U46619 induced tone by >70 % and to hyperpolarize the smooth muscle cell 
membrane by >15 mV.  All blocking drugs were allowed to equilibrate for 20 min before study except: 
nifedipine and ryanodine which produced immediate responses or whose effects were studied over a 20 
min period. In some experiments, endothelial cells were removed by gently rubbing the luminal surface 
with a human hair; subsequent relaxation of <15 % to SLIGRL (20 µM) was considered as successful 
removal. Smooth muscle cell tension and Em were measured simultaneously as previously described 
[35] and were recorded with the use of Powerlab system (AD instruments, Australia). Briefly, 
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individual smooth cells were impaled with a glass electrode (filled with 2 M KCl, tip resistance 60-100 
MΩ) held perpendicular to the cells. 
 
Simultaneous measurement of changes in [Ca2+]SMC and tension 
 
A segment of middle cerebral artery was mounted as described above except in a Mulvany-Halpern 
myograph designed for use on a confocal microscope (Model 120CW, Danish Myotechnology) and in 
MOPS buffer containing (mM): NaCl, 145; KCl, 4.7; CaCl2, 2.0; MgSO4, 1.17; MOPS, 2.0; NaH2PO4, 
1.2; glucose, 5.0; pyruvate, 2.0; EDTA, 0.02; NaOH, 2.75 (the pH of the solution was adjusted to 7.39-
7.41 at 37ºC using NaOH or HCl, as appropriate). The arteries were loaded with the calcium-sensitive 
fluorescent dye, Oregon Green 488 BAPTA-1 AM (10 µM; dissolved in DMSO and 0.02 % (w/v) 
Pluronic F-127) for 1 hour. After excitation at 488 nm, the fluorescence emission intensity at 515 nm 
was recorded using a spinning disc confocal microscope (Yokogawa CSU22, Japan) fitted with an 
Andor iXON DV887ECS-BV camera (Andor, UK) mounted on an Olympus IX70 inverted microscope 
(Olympus, Japan) using a water immersion objective (x40, aperture 0.8, working distance 3.3 mm, 
Olympus, Japan) and images (512 x 512 pixels, 20 Hz) stored for offline analysis (iQ, Andor). 
Following background subtraction, average, relative changes in [Ca2+]SMC were calculated as changes 
in intensity of fluorescence divided by fluorescence at time = 0 s (F/F0), within selected cell regions 
(5x5 pixels). 
 
Isolated smooth muscle cell patch clamp experiments 
 
Freshly dissected middle cerebral arteries were placed in ice-cold Ca2+-free isolation solution 
containing (mM): NaCl, 140; KCl, 4.7; MgCl2, 1.2; glucose, 10; and HEPES, 10 (pH 7.4). After 
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incubation on ice for 20 min, the arteries were transferred to Ca2+-free isolation solution, containing 
1 mg/ml albumin, 1mg/ml papain (Sigma), and 1 mg/ml dithiothreitol, and allowed to digest for 20 min 
at 37°C. The tissue was then transferred into a solution containing 0.1 mM CaCl2 and 1 mg/ml 
collagenase type H (Roche) + 1 mg/ml collagenase type F (Sigma). Following digestion for 10 min at 
37°C, the tissue was washed in isolation solution containing 1 mg/ml albumin and 0.1 mM CaCl2. After 
gentle trituration, cells were centrifuged for 5 min at 1000 rpm, the supernantant removed, and 
resuspended in fresh isolation solution.  The concentration of extracellular calcium was increased over 
the next 30 mins to 750 µM. Freshly isolated cells were maintained on ice for use on the same day. 
 
Cells were placed in a heated recording chamber (RC-25F, Warner Instruments) and left for ~10 min to 
adhere to the cover glass.  Cells were then continually superfused (~1 ml/min) with heated solution 
(SH-27B Inline Heater, Warner Instruments) via a multi-barrel gravity-fed perfusion system. 
Experiments were performed using an agar bridge (2% agar filled with 3 M KCl).  During seal 
formation, cells were superfused with physiological saline solution (PSS) containing  (mM): NaCl, 
140; KCl, 4; CaCl2, 1.5; MgCl2, 1.2; HEPES, 10; glucose, 10; pH=7.4.  To record membrane potential, 
the pipette solution contained (mM): KCl, 130; NaCl, 10; HEPES, 10; MgCl2, 0.5; CaCl2, 0.5; and 
Amphotericin B (200 µg/ml). To record L type calcium current (ICaL), the whole cell mode was used 
and Ba2+ was used as the charge carrier. Cells were perfused with solution containing (mM): NaCl, 
120; CsCl, 4; TEA-Cl, 10; BaCl2, 10; MgCl2, 1.2; HEPES, 10; glucose (pH=7.4).  The pipette solution 
contained (mM): CsCl, 130; MgCl2, 0.4; HEPES, 10; EGTA 2; CaCl2, 0.4; GTP, 0.5; MgATP, 5; 
pH=7.3.  The osmolarity of all solutions was measured and corrected to 300 ± 5 mOsm using mannitol.  
All electrophysiological recordings were performed at 37°C. 
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ICaL was recorded using a 1 s ramp protocol, from –100 to +80 mV from a holding potential of –80 mV 
at a frequency of 0.05 Hz.  Nifedipine (1 µM) was applied at the end of the protocol, and subtracted 
from the current records obtained in barium containing solution, and the data presented as nifedipine-
sensitive current. Cell membrane capacitance was measured using a 10 mV hyperpolarizing step and 
used to correct ICaL currents for cell size. Currents were expressed as current density (pA/pF).   Any cell 
exhibiting current rundown in control conditions was excluded from the analysis.  NONOate was 
freshly diluted with PSS, and infused via an injection port in the superfusion line directly upstream 
from the recording chamber.  In experiments with the sGC inhibitor ODQ, cells were incubated in 10 
µM ODQ for 15 mins, and it was also included in the perfusion solutions. 
 
Data were analyzed and leak subtracted offline using pClamp 8 (Axon Instruments). Values are 
expressed as mean ± SEM of n cells (from at least 3 animals). The paired two-tail t-test was used to 
compare parameters obtained in control and test conditions in the same cell. A non-paired t-test was 
used to compare the differences between groups of data. 
 
Solutions and drugs 
 
Exogenous K+ was added as an isotonic solution, and expressed as the final bath concentration. 
Caffeine, L-NAME (NG-nitro-L-arginine methyl ester), nifedipine, ryanodine, BayK 8644 and 
papaverine were all obtained from Sigma (UK). IbTx was obtained from Latoxan (France); DEA-
NONOate from Alexis (UK); ODQ (1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) from Tocris (UK); 
SLIGRL from Auspep (Australia); Oregon Green 488 BAPTA-AM from Molecular Probes (UK); 
TRAM-34 was a gift from Dr H. Wulff (University of California, Davis); and U46619 was from 
Calbiochem (UK). All drugs were made in 0.9 % NaCl except ryanodine, nifedipine, ODQ, U46619 
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and Amphortericin B in DMSO; NONOate in 0.01 M NaOH (and stored at -80 ºC); and (-) BayK 8644 
in EtOH. All subsequent dilutions of all drugs were made in 0.9 % NaCl and vehicle had no effect. 
NONOate dilutions were kept on ice in the dark and were discarded after 20 min. 
 
Statistical analysis 
 
Results are expressed as the mean ± SEM of n animals. Relaxation is expressed as the peak percentage 
reduction of the total vascular tone (from the myogenic tone to the tension/diameter following addition 
of papaverine, 150 µM) or as mN, as appropriate. Constriction is expressed in mN or as a percentage of 
maximal constriction induced by exogenous K+ (55 mM), as appropriate, all values were the peak 
values. When oscillations in membrane potential or tension were observed, values are the average of 10 
s. Graphs were drawn and statistical comparisons made using either Student’s t-test, or one-way 
ANOVA with Tukeys or Dunnetts post-hoc test using Prism software (Graphpad, USA). 
 
 
RESULTS 
 
Effect of inhibiting NO synthase, sGC, RYRs and BKCa-channels on myogenic tone 
 
Rat middle cerebral arteries exhibit myogenic tone in a wire myograph equivalent to ~15 % of the 
maximum tension the vessel can develop [18], and associated with a resting membrane potential (Em) 
of -50 ± 0.2 mV (n = 9). Addition of the NO synthase inhibitor, L-NAME (100 µM) evoked 
depolarization (to Em -43.7 ± 1.9 mV, n = 6) and constriction (increase in tension of 3.7 ± 0.5 mN, n = 
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7; Figure 1). In addition, oscillations in Em developed, temporally linked to oscillations in tension 
(Figure 1, Table 1). Fluorescence imaging revealed that in unstimulated control arteries, smooth muscle 
cells displayed spontaneous and asynchronous propagating Ca2+ waves (172 of 210 cells, Figure 1, 
online Movie 1). The oscillations occurred with a frequency of 0.27 ± 0.02 Hz (n = 21, Table 1) and 
were not associated with any change in tension (Figure 1). Addition of L-NAME increased the global 
[Ca2+]SMC (data not shown) associated with the development of synchronous Ca2+ oscillations between 
smooth muscle cells that clearly linked temporally to changes in tension (Figure 1, online Movie 2, 
Table 1). 
 
The BKCa-channel inhibitor iberiotoxin (IbTx, 100 nM) and the sGC inhibitor ODQ (10 µM) both 
mimicked this effect of L-NAME. Each caused depolarization (to Em -40.3 ± 1.8 and -35.5 ± 6.0 mV n 
= 5 and n = 3, respectively; Figure 2) and vasoconstriction (increases in tension of 3.7 ± 0.8 and 3.8 ± 
0.7 mN n = 6 and n = 3, respectively; Figure 2) associated with the development of oscillations in Em 
temporally linked to oscillations in tone (Table 1). Note that the vasomotion induced by ODQ was at a 
significantly lower frequency than that with either IbTx or L-NAME (Table 1). 
 
Inhibition of RYRs with ryanodine (10 µM) also mimicked the effect of L-NAME causing 
depolarization (13.5 ± 3.6 mV) and tension increases (2.3 ± 0.2 mN, n = 5), and associated 
development of synchronous Em oscillations temporally linked with tension oscillations (Figure 3, 
Table 1). Similarly, ryanodine stimulated synchronous Ca2+ oscillations in phase with tension changes 
(Figure 3, Table 1).  
 
Effect of L-NAME and ryanodine on oscillations in [Ca2+]SMC in the presence of nifedipine 
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As ryanodine and L-NAME each evoke constrictor responses associated with depolarization (and 
consequent calcium entry via VGCC) the effects of these drugs were assessed in the presence of the L-
type VGCC inhibitor, nifedipine (1 µM). Under control conditions, nifedipine alone hyperpolarized 
(6.4 ± 2.4 mV) and relaxed (0.76 ± 0.03 mN) myogenic tone (n = 4), associated with a slight but 
significant reduction in both the frequency (0.20 ± 0.02 Hz, n = 4, P < 0.01) and the number of cells 
exhibiting asynchronous propagating Ca2+ waves (to 70 %, 28 of 40 cells; Figure 4). Subsequent 
addition of L-NAME repolarized the smooth muscle Em (depolarization of 7.5 ± 3.8 mV, n = 4) and 
caused a small increase in tension (0.8 ± 0.01 mN, n = 4), returning Em and tension values close to 
values recorded in quiescent vessels. In the presence of nifedipine, L-NAME had no significant effect 
on the number of cells exhibiting asynchronous propagating Ca2+ waves (68 %, 27 of 40 cells) or the 
wave frequency (0.22 ± 0.02 Hz, n = 4; Figure 4). In contrast, ryanodine completely abolished these 
Ca2+ waves (to 0 in 60 cells; Figure 4). 
 
Effect of blocking VGCC and application of exogenous NO or caffeine on L-NAME-induced tone 
 
In vessels pre-constricted with L-NAME, nifedipine (1 µM) abolished oscillations in Em and caused a 
repolarization (hyperpolarization of 11.7 ± 1.9 mV, n = 3) to circa the resting membrane potential in 
the absence of NOS inhibition. This was associated with complete reversal of L-NAME induced tone 
(93.1 ± 1.6 %, n = 3). Furthermore, nifedipine caused a large decrease in [Ca2+]SMC (data not shown) 
and abolished the synchronous Ca2+ oscillations between SMC, unmasking the asynchronous 
propagating Ca2+ waves (compare Figure 4B to Figure 1B). 
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In vessels pre-constricted with L-NAME, application of caffeine (30 µM – 3 mM) induced 
concentration-dependent hyperpolarization and relaxation (log EC50: -3.43 ± 0.10; 3 mM: 16.4 ± 5.0 
mV and 91.8 ± 4.2 % relaxation, n = 8, Figure 5A). Hyperpolarization and relaxation to caffeine (1 
mM: 16.5 ± 2.0 mV and 82.6 ± 3.7 %, respectively, n = 6) were attenuated by IbTx (Figure 5A) and by 
ryanodine (1 mM: 4.4 ± 1.9 mV and 40.0 ± 30.9 %, respectively, n = 6). 
 
Application of the NO donor NONOate (3 nM – 1 µM) stimulated concentration dependent 
hyperpolarization and relaxation (log EC50: -7.48 ± 0.05; 1 µM: 13.3 ± 2.1 mV and 83.0 ± 2.5 % 
relaxation, n = 5, Figure 5B). The sGC inhibitor ODQ (1 µM) did not affect hyperpolarization to 
NONOate but significantly attenuated the relaxation (Figure 5B). Blockade of BKCa-channels with 
IbTx (100 nM) significantly inhibited both NONOate-induced hyperpolarization and relaxation (Figure 
5B). 
 
Effect of removing the endothelium on myogenic tone and the response to application of 
exogenous NO 
 
Following removal of the endothelium, cerebral artery smooth muscle cells were depolarized (Em -45.9 
± 2.2 mV, n = 12) and spontaneously developed tension (1.5 ± 0.2 mN, n = 12) sometimes (9 of 12 
records) associated with oscillations in both Em (amplitude: 4.5 ± 1.2 mV; frequency: 0.84 ± 0.20 Hz, n 
= 12) and tension. In these denuded cerebral arteries, L-NAME did not further increase tension (data 
not shown).  
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The NO donor, NONOate (3 nM – 1 µM) evoked concentration dependent hyperpolarization and 
relaxation in denuded arteries (logEC50: -7.50 ± 0.06; 1 µM: -9.2 ± 2.2 mV and 78.0 ± 7.9 % relaxation, 
n = 6, Figure 5C). Ryanodine (10 µM) caused a small increase in tone, which was associated with 
slight depolarization (Em -41.7 ± 1.0 mV, n = 12), and a significant increase in the amplitude of 
oscillations in Em (23.3 ± 2.7 mV; frequency: 1.24 ± 0.09 Hz, n = 12, Figure 5C). These oscillations 
were not coupled to a detectable tension change. Ryanodine markedly reduced the hyperpolarization 
produced by NONOate but did not significantly affect the relaxation. Interestingly, NONOate reduced 
the amplitude and frequency of ryanodine-mediated oscillations in Em (1 µM: Figure 5C). The addition 
of IbTx did not modify the effects of ryanodine, apart from further increasing the amplitude of 
oscillations by around 10 mV (amplitude significantly increased to 34.9 ± 3.4 mV, frequency 1.29 ± 
0.09 Hz, n = 8, Figure 5C). 
 
To further characterize the action of NO, experiments were performed to assess an action at VGCC. In 
endothelium-denuded arteries, IbTx had no significant effect on hyperpolarization and relaxation 
responses to NONOate (compare Figure 5C to Figure 6B). However in the additional presence of 
ODQ, the hyperpolarization and relaxation to NONOate were reduced (Figure 6A, 6B). Subsequent 
addition of the L-type VGCC opener BayK 8644 did not significantly alter membrane potential 
(hyperpolarization of 3.7 ± 3.8 mV) but contracted arteries (1.2 ± 0.2 mN, n = 5) and significantly 
increased both the frequency and amplitude of oscillations in Em (Figure 6C). In the presence of this 
combination of inhibitors, the hyperpolarization to NONOate was effectively abolished, and the 
relaxation to NONOate markedly reduced.  
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Direct action of NO on VGCC 
 
Isolated cells. The average resting Em of isolated smooth muscle cells was -51.1 ± 2.0 mV (n = 12). In 
these unstretched and unstimulated cells, Em tended to oscillate (amplitude of 15.4 ± 2.8 mV, n = 12), 
but a clear pattern was not observed (Figure 7A). In contrast, under similar conditions at 37ºC, the 
resting Em of smooth muscle cells isolated from mesenteric arteries tended to remain stable at -54.5 ± 
0.6 mV (with less frequent and lower amplitude oscillations of 5.2 ± 0.5 mV, n = 11). Addition of 1 
µM NONOate to the superfusion solution stimulated hyperpolarization and abolished the oscillations in 
Em (Figure 7A). In whole cell mode, steady state ICaL was recorded for 1 min using the ramp protocol. 
Application of NONOate (1 µM) to the bath induced a significant reduction in ICaL that was not 
inhibited by ODQ (Figure 7C, D, n = 6-7). The effect of NONOate on ICaL was time-dependent (Figure 
7D), so values were taken at 10 min following application of NONOate. 
 
 
DISCUSSION  
 
These data from the rat middle cerebral artery indicate that myogenic tone and vasomotion are 
normally suppressed by basal release of endothelium-derived NO that inhibits VGCC largely via sGC-
independent pathways. This can occur either through an effect at RYR and activation of smooth muscle 
cell BKCa-channels, or a direct action independent of voltage. The activation of BKCa-channels appears 
to involve in part an indirect action of NO due to stimulation of Ca2+ release from ryanodine-sensitive 
Ca2+ stores but also in part a direct action of NO on the KCa-channel. Therefore upon inhibition of 
NOS, smooth muscle cell depolarization due to closure of BKCa-channels and the removal of an 
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inhibitory influence, both lead to opening of VGCCs which is followed by a rise in [Ca2+]SMC and 
tension leading to arterial vasomotion. 
 
The finding that myogenic tone is normally suppressed by basal release of NO in rat middle cerebral 
arteries is consistent with previous studies using cerebral arteries [14-19] and a variety of other vessels 
that exhibit myogenic tone including small coronary arteries [11,12]. By suppressing myogenic tone, 
NO also suppresses vasomotion in the middle cerebral artery. Nifedipine fully reversed the effects of L-
NAME, reversing tension and abolishing synchronised oscillations in both Em and [Ca2+]SMC. Therefore 
it is apparent that opening VGCCs is essential for vasomotion to develop, consistent with many other 
vessels [1,36].  Despite this, we cannot rule out the involvement of ion other channels. Once the 
intracellular Ca2+ levels rise and the membrane depolarizes, other channels would be stimulated to 
open, including voltage-gated Na+-channels, Ca2+-activated Cl--channels, and KCa-channels. 
Furthermore, as both the endothelial and smooth muscle cells are coupled by homocellular and 
heterocellular gap junctions in this artery [37], it remains possible that the endothelium influences 
membrane potential through NO or other mediators. For example, changes in endothelial cell Ca2+ are 
responsible for the release of NO, so endothelial cell KCa-channels may also play a role in the observed 
changes in membrane potential. 
 
While basal release of NO is known to suppress myogenic tone (and vasomotion), the precise 
mechanisms are unclear. However, it is likely that NO acts via multiple mechanisms, a few of which 
are shown in Figure 8. NO can suppress the contractile apparatus of the smooth muscle cells via the 
cGMP pathway. Indeed, ODQ produced increases in tension and depolarization (similar to L-NAME, 
albeit with a lower frequency of vasomotion), suggesting that sGC somehow stimulates 
hyperpolarization, perhaps via an action at BKCa-channels through PKG-dependent mechanisms 
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[24,25] or by an action on RYRs [27,28]. In addition, our data are consistent with a cGMP-independent 
action of NO at BKCa-channels, because BKCa-channel-mediated hyperpolarization induced by the NO 
donor, NONOate, was not significantly attenuated by ODQ. This suggests that endogenous NO 
activates BKCa-channels either directly [21,22] or via stimulation of Ca2+ release (e.g. sparks) from 
ryanodine sensitive stores (by opening RYRs). Evidence for the latter comes from the ability of 
ryanodine to block NONOate induced hyperpolarization in endothelium-damaged vessels. Despite this 
block, NONOate was still able to reduce the frequency and amplitude of the depolarizing spikes 
(oscillations in Em) linked with the vasomotion generated by ryanodine. This suggests that NO acts to 
prevent the opening of the ion channel responsible for the depolarization. Further evidence consistent 
with a cGMP-independent action of NO on RYRs, was the ability of ryanodine to (a) stimulate 
vasomotion, mimicking the effect of NOS inhibition; and (b) inhibit the IbTx-sensitive 
hyperpolarization to caffeine.  
 
Although it is likely that a major component of NO-induced suppression of myogenic tone involves a 
stimulation of Ca2+ release events, our data argue against an essential role for NO in the activation of 
RYRs. In the presence of nifedipine, L-NAME did not markedly prevent the basal asynchronous 
propagating Ca2+ waves, whereas ryanodine did. This is in contrast to previous observations in cerebral 
arteries by Mandala et al [26], who suggested that NO was absolutely essential for RYR activation (and 
thus for activation of BKCa-channels) because spontaneous Ca2+ sparks were reduced by around 50 % 
with NOS inhibitors or endothelium removal. However, following on from our observations it is likely 
that asynchronous propagating Ca2+ waves were masked by the Ca2+ influx through the L-type VGCCs 
and development of synchronous Ca2+ oscillations, as observed in the present study. Therefore, while 
the activation of BKCa-channels by NO likely involves direct stimulation of RYR-controlled Ca2+ 
stores, this action of NO is not an essential step in the activation of RYR. It follows that as RYR 
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stimulation is not necessarily associated with NO, an as yet unidentified process may also modulate 
vasomotion. In support of this conclusion, inhibition of RYR in the absence of a functional 
endothelium (and therefore NO synthesis) resulted in a small increase in tension as well as 
development of large, regular depolarizing oscillations in Em.   
 
Further experiments in the absence of functional endothelium showed that NONOate appears to 
directly inhibit VGCCs. In the presence of both IbTx and ODQ, NONOate responses mimicked those 
of nifedipine under control conditions and in the presence of L-NAME, that is, complete block of the 
oscillations in Em associated with a small hyperpolarization, and relaxation. This direct effect of 
NONOate on VGCC was confirmed in isolated smooth muscle cells, where ICaL was markedly reduced. 
The effect of NONOate on ICaL in the isolated cells appears to be at least in part via a direct action on 
the channel protein or associated proteins, rather than via a cGMP-dependent mechanism.  This is 
consistent with previous findings in the carotid body, where Summers et al. (1999) showed that NO-
mediated inhibition of ICaL occurs via S-nitrosylation of the channel protein, and that S-alkylation of the 
free cysteine residues by NEM prevented the modulation by the NO donor sodium nitroprusside, rather 
than via the activation of sGC.  
 
Further evidence for the action of NO on ICaL in our studies to be induced by nitrosylation rather than 
via the cGMP/PKG pathway may come from the time-course of NONOate induced inhibition, which 
took minutes to tens of minutes to occur.  Previous studies of neuronal BKCa channels suggest that not 
only does nitrosylation require a higher concentration of NO than the PKG pathway, but it develops 
with a much slower time-course [38,39]. Further, transient receptor potential (TRP) channels can be 
activated by NO donors, TRPC6 channels being PKG-dependent, whereas TRPC5 channels are more 
slowly activated via S-nitrosylation [40]. 
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The action of NO at VGCC was fully reversed by adding the direct opener of L-type VGCC, 
suggesting the sites of action are independent. Although there is evidence that both NO and BayK 8644 
each evoke their effects on the L-type VGCC via the pore-forming α1c-subunit, BayK 8644, which 
competitively competes with nifedipine, binds from the extracellular surface to access the 
dihydopyridine receptor site within the channel [41,42]. The site of NO-induced VGCC modulation by 
nitrosylation still remains to be elucidated.  However, studies on other ion channels and transporters 
indicate that S-nitrosylation sites are primarily hydrophobic intracellular cysteine residues, flanked by 
positively charged basic residues [43].  In the skeletal muscle ryanodine receptor, the NO nitrosylation 
site has been identified as a hydrophobic cysteine residue at position 3635 of the calmodulin-binding 
domain [44].  Indeed, there is also evidence that VGCC function can be impaired by nitrosylation of an 
intracellular tyrosine residue  (Y2134) situated in the src kinase protein binding domain of the carboxy 
terminal of the α1c-subunit [45].  
 
In summary, in rat middle cerebral arteries a basal release of NO from the endothelium suppresses 
myogenic tone. This suppression of myogenic tone is due, at least in part, to the ability of NO to 
stimulate BKCa-channels by activating ryanodine-sensitive Ca2+ stores. Following inhibition of NOS, 
the BKCa-channels close leading to depolarization, with an associated increase in tension and the 
development of vasomotion. Therefore, our data indicate that basal NO-release represents an important 
controlling mechanism on myogenic tone in cerebral arteries. In disease states where NO synthesis is 
compromised, disruption of this constitutive suppression of myogenic tone would be predicted to 
increase significantly the risk of brain ischaemia. 
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Table 1.  Amplitude and frequency of smooth muscle cell Em, tension and synchronous Ca2+ 
oscillations.  
 
SMC Em [Ca2+]SMC 
Oscillation amplitude Oscillation frequency Oscillation frequency 
 
Em  
(mV) 
Tension 
(mN) 
Em 
(Hz) 
Tension 
(Hz) 
Ca2+ 
(Hz) 
Tension 
(Hz) 
L-NAME 16.4 ± 1.8 0.14 ± 0.2  0.85 ± 0.06  0.84 ± 0.05  0.75 ± 0.05  0.76 ± 0.04  
IbTx 19.7 ± 2.3  0.11 ± 0.02   0.97 ± 0.05  0.96 ± 0.06  ND ND 
ODQ 8.1 ± 0.7* 0.13 ± 0.02  0.57 ± 0.06* 0.56 ± 0.07* ND ND 
Ryanodine 19.5 ± 3.4 0.06 ± 0.01* 1.08 ± 0.06  1.06 ± 0.06  1.04 ± 0.04* 1.01 ± 0.05* 
 
Data expressed as mean ± SEM, n = 4-11. Time-matched, paired values obtained from simultaneous 
records of either Em and tension or Ca2+ and tension. *P<0.05 significant difference from L-NAME. 
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Figure 1. Spontaneous nitric oxide release prevents vasomotion. Original traces showing (A) 
simultaneous recordings of membrane potential (upper panels) and tension (lower panels) or (B) 
simultaneous recordings of [Ca2+]SMC (upper 2 sets of panels) and tension (lower panels) under control 
resting conditions (left hand panels) or in the presence of the NO synthase inhibitor, L-NAME (100 
µM; right hand panels), in rat middle cerebral arteries. Under control conditions, membrane potential 
and tension are relatively stable, and at the same time, [Ca2+]SMC is constantly oscillating but these 
oscillations are asynchronous between smooth muscle cells and can be observed as waves passing 
along cells (asynchronous propagating Ca2+ waves). In the presence of L-NAME, the smooth muscle 
cells depolarized and developed regular depolarizing oscillations, which were associated with increased 
tension and oscillations in tension; the peaks in Em immediately preceded peaks in tension. In the 
presence of L-NAME oscillations in [Ca2+]SMC were now synchronized and regular (synchronous Ca2+  
oscillations) and were temporally linked to oscillations in tension. The top coloured traces correspond 
to the average F/F0 in 3 cells indicated by filled coloured squares on the images of the preparations (C), 
and the black traces are the average change in fluorescence from 10 equivalent regions in separate 
cells. The lower coloured traces correspond to the percentage maximum change in fluorescence in 
single cells indicated by the open coloured squares in (C). Bar = 20 µm. Movie files corresponding to 
the cropped regions shown in Control and L-NAME (dashed lines) are available online. Summary data 
are shown in Table 1. 
 
Figure 2.  Spontaneous activation of BKCa-channels and sGC prevent vasomotion. Original traces 
showing the effect of either (A) the BKCa-channel inhibitor, IbTx (100 nM) or (B) the sGC cyclase 
inhibitor, ODQ (10 µM) on simultaneous recordings of membrane potential (upper panels) and tension 
(lower panels). Both IbTx and ODQ caused depolarization and increased tension and a development of 
vasomotion. 
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Figure 3.  Spontaneous activation of RYRs prevents vasomotion. Original traces of (A) simultaneous 
recordings of membrane potential and tension or (B) simultaneous recordings of [Ca2+]SMC and tension. 
The traces show recordings obtained in the presence of the inhibitor of RYRs (ryanodine, 10 µM). 
Ryanodine caused depolarization and increased tension of the middle cerebral artery associated with 
development of depolarizing oscillations in Em that were temporally coupled to changes in tension. 
Ryanodine also caused development of synchronous Ca2+ oscillations that were temporally linked to 
oscillations in tension.  [Ca2+]SMC responses from 3 randomly selected cells are displayed (colour) as 
well as the 10 cell average (black). 
 
Figure 4. Spontaneous nitric oxide release does not inhibit control, asynchronous propagating Ca2+ 
waves. Original traces showing the basal, asynchronous propagating Ca2+ waves from 3 representative 
cells (colour) and the 10 cell average (black; upper traces) and associated tension records (lower traces) 
in rat middle cerebral arteries (A) in the presence of the L-type VGCC inhibitor, nifedipine (1 µM) and 
(B) the combination of nifedipine and the NO synthase inhibitor, L-NAME (100 µM). Under control 
conditions changes in [Ca2+]SMC were not synchronized between individual cells and were not coupled 
to changes in tension (as in Figure 1A). Nifedipine had no effect on the size of the asynchronous 
propagating Ca2+ waves. Subsequent addition of L-NAME also had no effect on these Ca2+ waves. 
Average data are shown in (C) showing the frequency of Ca2+ waves and the percentage of cells 
exhibiting this behavior (left panel) and the associated tension (right panel) in control vessels and in the 
presence of nifedipine, nifedipine + L-NAME and nifedipine + ryanodine (10 µM). Ryanodine 
completely abolished the Ca2+ waves in all cells of all vessels tested (60 cells). Data expressed as 
means ± SEM. 
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Figure 5.  Caffeine and NONOate stimulate hyperpolarization and relaxation. Concentration response 
curves showing hyperpolarization (left panels) and relaxation (right panels) produced by caffeine (A) 
or the NO donor DEA-NONOate (B) in endothelium-intact (+EC) or endothelium-damaged arteries (-
EC, C). Vessels were pre-incubated with L-NAME (100 µM), IbTx (100 nM), ODQ (10 µM) and/or 
ryanodine (10 µM). Data are expressed as mean ± SEM, n = 4-9. * Significant difference from L-
NAME (+EC) or control (-EC), P < 0.05; † Significant difference from Baseline, P < 0.05. 
 
Figure 6. Application of exogenous NO (NONOate 3 nM – 3 µM) appears to directly inactivate 
VGCCs in endothelium-denuded middle cerebral arteries. Original trace (A) showing that in the 
combined inhibition of BKCa-channels (IbTx, 100 nM) and sGC (ODQ, 10 µM), NONOate  induces a 
reduction in membrane potential oscillation frequency and amplitude  (upper trace) that is associated 
with relaxation (lower trace). The effects of NONOate were fully reversed by an opener of L-type 
VGCCs (BayK 8644, 1 µM). Highlighted regions (gray lines) are reproduced in an extended time base 
to demonstrating that BayK 8644 fully reverses the effects of NONOate. Also shown are concentration 
response curves (B) showing the effect of NONOate on membrane potential and tension, as well as 
histograms (C) that show the effect of NONOate on oscillation frequency and amplitude in the 
presence of IbTx, the combined presence of IbTx and ODQ and in the additional presence of BayK 
8644. Note that following inhibition of BKCa and sGC, NONOate-mediated relaxation does not seem to 
involve a true hyperpolarization but results from a reduction in both frequency and amplitude of the 
oscillations in membrane potential. Data are expressed as mean ± SEM, n = 4-5. *P<0.05 significant 
difference from control. †P<0.05 significant difference from baseline. 
 
Figure 7. NONOate inhibits VGCC via a sGC-independent mechanism. In isolated smooth muscle 
cells at 37ºC under current-clamp conditions (A) the resting Em oscillated. Addition of 1 µM NONOate 
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(indicated by arrow) hyperpolarized the cell and abolished the oscillations in Em. (B) The voltage 
protocol for detecting ICaL (top) resulted in inward current that was reduced by 1 µM NONOate 
(bottom). (C) Mean current voltage relationships under both control conditions (n = 6, left) and after 
pretreatment with ODQ (n = 7, right) show that the inhibition of ICaL by 1 µM NONOate was not 
sensitive to ODQ, and (D) the peak current was reduced by approximately 50% under both conditions. 
Data are expressed as mean ± SEM. *P<0.05 significant difference from control.  Panel E shows the 
effect of 1 µM NONOate (added at arrow) on peak ICaL amplitude over time, for data shown in panels 
C and D. NONOate-induced ICaL inhibition took minutes to occur, and was not due to current rundown 
(Time control). 
 
Figure 8.  Schematic depicting actions of NO in cerebral artery smooth muscle cells. Release of NO 
from endothelial cells can suppress vasomotion via multiple mechanisms. (i) Stimulation of sGC can 
relax smooth muscle cells via voltage-independent pathways. (ii) NO can directly activate BKCa-
channels, leading to hyperpolarization, closure of VGCC and relaxation. (iii) The action of NO on 
BKCa-channel activity can be indirect, via a direct action of NO at RYRs, or (iv) via an intermediate 
(e.g. sGC/PKG). RyRs are also activated by NO-independent mechanisms (v) including those related to 
store filling via the Ca2+-ATPase (SERCA). This depiction is based on the close association of RyRs to 
BKCa-channels, which are spatially separated from the Ca2+ release and influx mechanisms associated 
with contraction [46,47].  
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Online supplementary material 
 
The online supplementary material shows two movies of the Ca2+ events in middle cerebral arteries 
mounted in a wire myograph. Under control conditions (Movie 1) spontaneous, asynchronous 
propagating Ca2+ waves can be observed in the individual smooth muscle cells. After the addition of L-
NAME, the artery contracted and developed vasomotion. Under these conditions, the synchronous Ca2+ 
oscillations were observed (Movie 2). See Figure 1 for traces of tension and [Ca2+]SMC. 
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